SBIR/STTR Research Award

STTR Phase I: Production and Characterization of Recombinant Gelatin in Transgenic Rice Cell Cultures

Award identifier aa0752ba2c96f345d1cf6edf876a4f6417af8abd64cacb73d2dd90a914b28ec5Awarding agency National Science Foundation

Award amount

$100,000

Program and phase

STTR · Phase I

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
FIBROGEN, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

This Small BusinessTechnology Transfer Research (STTR) Phase I project will evaluate a rice cell culture system for the production of recombinant gelatin (rGelatin) designed for improved capsule performance. The commercial application of this project will be on capsule manufacturers serving the pharmaceutical industry. Plant systems used to create rGelatin will offer a lower cost production system compared to other recombinant platforms. Such a recombinant product will be safer than animal-derived gelatin and more acceptable to many consumers. Further, the proposed technology will have the potential to produce customized rGelatin for specific applications.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.